CAVA Group, Inc. (CAVA) Stock Forecast
Data as of Oct 31, 2026Consumer Cyclical · Current price $58.35 (-1.56%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 25, 2026 | Jake Bartlett | Truist Financial | $85.00 | +45.7% |
| Feb 25, 2026 | Arun Viswanathan | RBC Capital | $133.00 | +127.9% |
| Feb 25, 2026 | Brian Mullan | Piper Sandler | $85.00 | +45.7% |
| Feb 23, 2026 | Jake Bartlett | Truist Financial | $80.00 | +37.1% |
| Feb 18, 2026 | Dennis Geiger | UBS | $69.00 | +18.3% |
| Jan 9, 2026 | Nick Setyan | Mizuho Securities | $64.00 | +9.7% |
| Jan 9, 2026 | Sarang Vora | Telsey Advisory | $85.00 | +45.7% |
| Jan 8, 2026 | Jake Bartlett | Truist Financial | $78.00 | +33.7% |
| Jan 7, 2026 | Jeffrey Bernstein | Bernstein | $70.00 | +20.0% |
| Nov 5, 2025 | Chris O'Cull | Stifel Nicolaus | $75.00 | +28.5% |
| Nov 5, 2025 | Christine Cho | Goldman Sachs | $68.00 | +16.5% |
| Nov 5, 2025 | Danilo Gargiulo | Bernstein | $80.00 | +37.1% |
| Nov 3, 2025 | Dennis Geiger | UBS | $61.00 | +4.5% |
| Oct 31, 2025 | Chris O'Cull | Stifel Nicolaus | $100.00 | +71.4% |
| Oct 20, 2025 | Christine Cho | Goldman Sachs | $74.00 | +26.8% |
| Aug 13, 2025 | David Tarantino | Robert W. Baird | $95.00 | +62.8% |
| Aug 13, 2025 | Christopher Carril | KeyBanc | $85.00 | +45.7% |
| Aug 13, 2025 | Jeffrey Bernstein | Bernstein | $74.00 | +26.8% |
| Jul 14, 2025 | Brian Harbour | Morgan Stanley | $107.00 | +83.4% |
| Apr 7, 2025 | David Tarantino | Robert W. Baird | $105.00 | +79.9% |
Top Analysts Covering CAVA
CAVA vs Sector & Market
| Metric | CAVA | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.29 | 2.48 | 2.41 |
| Analyst Count | 35 | 12 | 19 |
| Target Upside | +51.3% | +248.0% | +21.5% |
| P/E Ratio | 111.85 | 16.25 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $1.43B | $1.46B | $1.48B | 19 |
| 2027-12-28 | $1.42B | $1.75B | $1.82B | 19 |
| 2028-12-28 | $2.13B | $2.13B | $2.13B | 10 |
| 2029-03-28 | $642M | $692M | $711M | 8 |
| 2029-06-28 | $536M | $577M | $594M | 8 |
| 2029-09-28 | $543M | $586M | $602M | 8 |
| 2029-12-28 | $502M | $542M | $557M | 12 |
| 2030-03-28 | $745M | $804M | $826M | 8 |
| 2030-06-28 | $621M | $670M | $688M | 8 |
| 2030-09-28 | $628M | $678M | $697M | 8 |
| 2030-12-28 | $580M | $625M | $643M | 12 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $0.42 | $0.52 | $0.56 | 17 |
| 2027-12-28 | $0.65 | $0.72 | $0.81 | 18 |
| 2028-12-28 | $1.00 | $1.05 | $1.14 | 8 |
| 2029-03-28 | $0.00 | $0.00 | $0.00 | 5 |
| 2029-06-28 | $0.00 | $0.00 | $0.00 | 6 |
| 2029-09-28 | $0.00 | $0.00 | $0.00 | 7 |
| 2029-12-28 | $0.00 | $0.00 | $0.00 | 8 |
| 2030-03-28 | $0.00 | $0.00 | $0.00 | 8 |
| 2030-06-28 | $0.00 | $0.00 | $0.00 | 9 |
| 2030-09-28 | $0.00 | $0.00 | $0.00 | 10 |
| 2030-12-28 | $0.00 | $0.00 | $0.00 | 11 |
Frequently Asked Questions
What is the analyst consensus for CAVA?
The consensus among 35 analysts covering CAVA Group, Inc. (CAVA) is Buy with an average price target of $88.89.
What is the highest price target for CAVA?
The highest price target for CAVA is $200.00, set by Arun Sundaram at CFRA on 2024-11-13.
What is the lowest price target for CAVA?
The lowest price target for CAVA is $41.00, set by Brian Harbour at Morgan Stanley on 2023-10-11.
How many analysts cover CAVA?
35 analysts have issued ratings for CAVA Group, Inc. in the past 12 months.
Is CAVA a buy or sell right now?
Based on 35 analyst ratings, CAVA has a consensus rating of Buy (2.29/5) with a +51.3% upside to the consensus target of $88.89.
What are the earnings estimates for CAVA?
Analysts estimate CAVA will report EPS of $0.52 for the period ending 2026-12-28, with revenue estimated at $1.46B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.